Weight Loss & Fat Reduction
Incretin receptor agonists, amylin analogues, and metabolic modulators.
Includes single, dual, and triple receptor agonists alongside lipolytic and mitochondrial-derived compounds. Multiple vial sizes available for each sequence.
Semaglutide
10 mg20 mg30 mg40 mgTirzepatide
5 mg10 mg15 mg20 mg+3Retatrutide
5 mg10 mg15 mg20 mg+3Mazdutide
10 mgLiraglutide
5 mg10 mg30 mgCagrilintide
5 mg10 mgCagrisema (Cagrilintide 2.5 mg + Semaglutide 2.5 mg)
2.5 mg + 2.5 mgSurvodutide
10 mgAOD-9604
5 mg10 mgHGH-191AA (Somatropin)
10 iu12 iu15 iu24 iu+1Adipotide (FTPP)
5 mg10 mgL-Carnitine
600 mg1200 mg
Lemon Bottle Lipolytic Solution
10 mLLipo-C Lipotropic Solution
10 mL (LC216)10 mL (LC526)MOTS-c
10 mg20 mg40 mgSLU-PP-332
5 mg10 mg5-Amino-1MQ
5 mg10 mg50 mg
Receptor Agonist Classes
This group spans GLP-1 receptor agonists, dual GLP-1/GIP agonists, triple GLP-1/GIP/glucagon agonists, and amylin analogues. Receptor coverage is the primary distinction between them and determines which research questions each compound suits.
Newer Agonists
Retatrutide, Survodutide, and Mazdutide are more recent entrants with broader receptor coverage than earlier single-target agonists. Cagrilintide acts on amylin receptors and is commonly studied alongside an incretin agonist; Cagrisema supplies both in one vial.
Storage Sensitivity
Larger peptide agonists in this class are sensitive to freeze-thaw cycling. Reconstitute only the volume required and avoid repeated temperature transitions.
Please Read Our Disclaimer Below
All products are supplied strictly for laboratory research and development. Nothing sold here is intended for human, veterinary, or household use. Statements on this page have not been evaluated by any food and drug regulatory authority.